Return to homepagePandemic Pact

Characterising the effects of immune-modulating drugs on the T cell immune response to COVID 19

  • Funded by British Society for Antimicrobial Chemotherapy (BSAC)
  • Total publications:0 publications

Grant number: BSAC-COVID-07

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $30,087.5

  • Funder

    British Society for Antimicrobial Chemotherapy (BSAC)

  • Principal Investigator

    Anna Schurich

  • Research Location

    Canada

  • Lead Research Institution

    King's College London, London, England

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract